Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $83.1200 (1.88%) ($80.3400 - $83.6300) on Fri. Nov. 20, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.53% (three month average) | RSI | 51 | Latest Price | $83.1200(1.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.1% a day on average for past five trading days. | Weekly Trend | LGND declines -2.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(55%) IWO(53%) IWM(50%) XBI(50%) IWC(49%) | Factors Impacting LGND price | LGND will decline at least -1.265% in a week (0% probabilities). VIXM(-23%) UUP(-17%) VXX(-15%) UNG(-3%) USO(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.265% (StdDev 2.53%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $77.86(-6.33%) | Inflection Point | Yes | Resistance Level | $83.99 | 5 Day Moving Average | $82.26(1.05%) | 10 Day Moving Average | $82.74(0.46%) | 20 Day Moving Average | $83.99(-1.04%) | To recent high | -27.7% | To recent low | 3.4% | Market Cap | $1.336b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |